Literature DB >> 27147668

Intrauterine growth restriction programs an accelerated age-related increase in cardiovascular risk in male offspring.

John Henry Dasinger1, Suttira Intapad1, Miles A Backstrom1, Anthony J Carter1, Barbara T Alexander2.   

Abstract

Placental insufficiency programs an increase in blood pressure associated with a twofold increase in serum testosterone in male growth-restricted offspring at 4 mo of age. Population studies indicate that the inverse relationship between birth weight and blood pressure is amplified with age. Thus, we tested the hypothesis that intrauterine growth restriction programs an age-related increase in blood pressure in male offspring. Growth-restricted offspring retained a significantly higher blood pressure at 12 but not at 18 mo of age compared with age-matched controls. Blood pressure was significantly increased in control offspring at 18 mo of age relative to control counterparts at 12 mo; however, blood pressure was not increased in growth-restricted at 18 mo relative to growth-restricted counterparts at 12 mo. Serum testosterone levels were not elevated in growth-restricted offspring relative to control at 12 mo of age. Thus, male growth-restricted offspring no longer exhibited a positive association between blood pressure and testosterone at 12 mo of age. Unlike hypertension in male growth-restricted offspring at 4 mo of age, inhibition of the renin-angiotensin system with enalapril (250 mg/l for 2 wk) did not abolish the difference in blood pressure in growth-restricted offspring relative to control counterparts at 12 mo of age. Therefore, these data suggest that intrauterine growth restriction programs an accelerated age-related increase in blood pressure in growth-restricted offspring. Furthermore, this study suggests that the etiology of increased blood pressure in male growth-restricted offspring at 12 mo of age differs from that at 4 mo of age.
Copyright © 2016 the American Physiological Society.

Entities:  

Keywords:  accelerated aging; blood pressure; cardiovascular risk; low birth weight; renin-angiotensin system

Mesh:

Substances:

Year:  2016        PMID: 27147668      PMCID: PMC5005278          DOI: 10.1152/ajprenal.00123.2016

Source DB:  PubMed          Journal:  Am J Physiol Renal Physiol        ISSN: 1522-1466


  45 in total

1.  Growth and chronic disease: findings in the Helsinki Birth Cohort.

Authors:  David J P Barker; Clive Osmond; Eero Kajantie; Johan G Eriksson
Journal:  Ann Hum Biol       Date:  2009 Sep-Oct       Impact factor: 1.533

2.  Longitudinal effects of aging on serum total and free testosterone levels in healthy men. Baltimore Longitudinal Study of Aging.

Authors:  S M Harman; E J Metter; J D Tobin; J Pearson; M R Blackman
Journal:  J Clin Endocrinol Metab       Date:  2001-02       Impact factor: 5.958

3.  Arterial pressure regulation. Overriding dominance of the kidneys in long-term regulation and in hypertension.

Authors:  A C Guyton; T G Coleman; A V Cowley; K W Scheel; R D Manning; R A Norman
Journal:  Am J Med       Date:  1972-05       Impact factor: 4.965

4.  Accelerated aging of reproductive capacity in male rat offspring of protein-restricted mothers is associated with increased testicular and sperm oxidative stress.

Authors:  Guadalupe L Rodríguez-González; Luis A Reyes-Castro; Claudia C Vega; Lourdes Boeck; Carlos Ibáñez; Peter W Nathanielsz; Fernando Larrea; Elena Zambrano
Journal:  Age (Dordr)       Date:  2014-10-30

5.  Aging and human hormonal and pressor responsiveness to angiotensin II infusion with simultaneous measurement of exogenous and endogenous angiotensin II.

Authors:  J Duggan; J Nussberger; S Kilfeather; K O'Malley
Journal:  Am J Hypertens       Date:  1993-08       Impact factor: 2.689

6.  Postnatal modulation of prenatally programmed hypertension by dietary Na and ACE inhibition.

Authors:  Jennifer Manning; V Matti Vehaskari
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2004-09-30       Impact factor: 3.619

7.  Altered renal vascular responses in the aging rat kidney.

Authors:  J E Tank; J P Vora; D C Houghton; S Anderson
Journal:  Am J Physiol       Date:  1994-06

8.  Angiotensin II-mediated vascular changes in aged offspring rats exposed to perinatal nicotine.

Authors:  Hehua Tao; Can Rui; Jianli Zheng; Jiaqi Tang; Lei Wu; Aiping Shi; Ningjing Chen; Rui He; Chonglong Wu; Jiayue Li; Xiaohui Yin; Peiwen Zhang; Zhoufeng Zhu; Jianying Tao; Jianping Xiao; Caiping Mao; Zhice Xu
Journal:  Peptides       Date:  2013-03-14       Impact factor: 3.750

9.  Hypertension Prevalence and Control Among Adults: United States, 2011-2014.

Authors:  Sung Sug Sarah Yoon; Margaret D Carroll; Cheryl D Fryar
Journal:  NCHS Data Brief       Date:  2015-11

10.  Normal lactational environment restores nephron endowment and prevents hypertension after placental restriction in the rat.

Authors:  Mary E Wlodek; Amy Mibus; Adeline Tan; Andrew L Siebel; Julie A Owens; Karen M Moritz
Journal:  J Am Soc Nephrol       Date:  2007-04-18       Impact factor: 10.121

View more
  4 in total

1.  Ouabain Protects Nephrogenesis in Rats Experiencing Intrauterine Growth Restriction and Partially Restores Renal Function in Adulthood.

Authors:  Liang Chen; Jing Yue; Shulin Zhou; Yali Hu; Juan Li
Journal:  Reprod Sci       Date:  2020-08-07       Impact factor: 3.060

2.  Postnatal resveratrol supplementation improves cardiovascular function in male and female intrauterine growth restricted offspring.

Authors:  Amin Shah; Anita Quon; Jude S Morton; Sandra T Davidge
Journal:  Physiol Rep       Date:  2017-01

3.  A Maternally Sequestered, Biopolymer-Stabilized Vascular Endothelial Growth Factor (VEGF) Chimera for Treatment of Preeclampsia.

Authors:  Omar C Logue; Fakhri Mahdi; Heather Chapman; Eric M George; Gene L Bidwell
Journal:  J Am Heart Assoc       Date:  2017-12-08       Impact factor: 5.501

4.  Testosterone is protective against impaired glucose metabolism in male intrauterine growth-restricted offspring.

Authors:  Suttira Intapad; John Henry Dasinger; Joel M Fahling; Miles A Backstrom; Barbara T Alexander
Journal:  PLoS One       Date:  2017-11-16       Impact factor: 3.240

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.